CME Program and Slide Decks Thrombosis Scientific Poster Session and Clinical Update
Our expert faculty selected 20 clinical trials which were displayed as posters at the Thrombosis Scientific Poster Session and Clinical Update, on December 9, 2007, in Atlanta, Georgia. These trials, previously presented or published, provide critical new data and serve as the foundation for discussion of new evidence in the management of thrombosis. We have included each poster here for you to view and/or download.
We welcome you to view the information for educational purposes.
ABSTRACTS
 download abstracts
Abstract Booklet
Selected meeting abstracts from ISTH 2007, ASH 2007, and published journal articles.
POSTERS
LOW-MOLECULAR WEIGHT HEPARIN
poster  slides
Anticoagulation with LMWH in Pregnant Patients with Mechanical Heart Valves
Quinn J, et al.
poster slides
Anticoagulation in Patients with Chemotherapy-induced Thrombocytopenia
Polizzotto M, Opat S.
poster slides
EXCLAIM
Tapson V, et al.
ORAL DIRECT THROMBIN INHIBITOR
poster slides
Dabigatran: BISTRO I
Eriksson B, et al.
poster slides
Dabigatran: BISTRO II
Eriksson B, et al.
poster slides
Dabigatran: Effective and Safe for Prevention of Venous Thromboembolism
Caprini J, et al.
poster slides
Dabigatran: Extended Prevention of Venous Thromboembolism Following THR
Eriksson B, et al.
poster slides
Dabigatran: Prevention of Venous Thromboembolism Following TKA
Friedman R, et al.
ORAL DIRECT FACTOR Xa INHIBITORS
poster slides
YM150 Phase II Dose Escalation Study: Prevention of Venous Thromboembolism
Eriksson B, et al.
poster slides
Apixaban: Dose Finding Study for the Treatment of Acute Symptomatic Deep Vein Thrombosis
Buller H
poster slides
Rivaroxaban: Prevention of Venous Thromboembolism After TKR, a Phase II Dose-ranging Study
Turpie A, et al.
poster slides
Rivaroxaban: Prevention of Venous Thromboembolism After THR
Eriksson B, et al.
poster slides
Rivaroxaban: RECORD I
Eriksson B, et al.
poster slides
Rivaroxaban: RECORD II
Kakkar A, et al.
poster slides
Rivaroxaban: RECORD III (VTE Prevention After TKR)
Lassen M, et al.
poster slides
Rivaroxaban: RECORD III (Impact on Healthcare Costs)
Kwong L, et al.
poster slides
Rivaroxaban: Once- or Twice-Daily Dosing Treatment of Deep Vein Thrombosis
Buller H, Agnelli G
poster slides
Rivaroxaban: Pharmacokinetics and Pharmacodynamics (Once- and Twice-daily Dosing)
Eriksson B, et al.
poster slides
Rivaroxaban: Predictable Pharmacokinetics and Pharmacodynamics (Treatment of DVT)
Mueck W, et al.
poster slides
Rivaroxaban: A Potential Anticoagulant for Patients with Heparin-Induced Thrombocytopenia
Walenga J, et al.
|
